Global Antisense Oligonucleotides Supply, Demand and Key Producers, 2023-2029

Page: 124

Published Date: 22 Feb 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

The global Antisense Oligonucleotides market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Antisense oligonucleotides (ASOs) are 15–25 nt oligonucleotides designed to tie complementary RNA targets for the degradation. They are synthesized so that they can be used to block disease processes by altering the synthesis of a specific protein.

This report studies the global Antisense Oligonucleotides demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Antisense Oligonucleotides, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Antisense Oligonucleotides that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Antisense Oligonucleotides total market, 2018-2029, (USD Million)
Global Antisense Oligonucleotides total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Antisense Oligonucleotides total market, key domestic companies and share, (USD Million)
Global Antisense Oligonucleotides revenue by player and market share 2018-2023, (USD Million)
Global Antisense Oligonucleotides total market by Type, CAGR, 2018-2029, (USD Million)
Global Antisense Oligonucleotides total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Antisense Oligonucleotides market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Ionis Pharmaceuticals, Sarepta Therapeutics, Biogen, Alnylam Pharmaceuticals, Antisense Therapeutics, Isarna Therapeutics, Arrowhead Pharmaceuticals, Atlantic Pharmaceuticals and Enzon Pharmaceuticals, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Antisense Oligonucleotides market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Antisense Oligonucleotides Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Antisense Oligonucleotides Market, Segmentation by Type
    RNA Antisense Oligonucleotides
    DNA Antisense Oligonucleotides

Global Antisense Oligonucleotides Market, Segmentation by Application
    Hospitals
    Clinic
    Others

Companies Profiled:
    Ionis Pharmaceuticals
    Sarepta Therapeutics
    Biogen
    Alnylam Pharmaceuticals
    Antisense Therapeutics
    Isarna Therapeutics
    Arrowhead Pharmaceuticals
    Atlantic Pharmaceuticals
    Enzon Pharmaceuticals
    Bio-Path Holdings
    GlaxoSmithKline
    Geron
    ICO Therapeutics
    Marina Biotech
    RXi Pharmaceuticals

Key Questions Answered
1. How big is the global Antisense Oligonucleotides market?
2. What is the demand of the global Antisense Oligonucleotides market?
3. What is the year over year growth of the global Antisense Oligonucleotides market?
4. What is the total value of the global Antisense Oligonucleotides market?
5. Who are the major players in the global Antisense Oligonucleotides market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Antisense Oligonucleotides Introduction
    1.2 World Antisense Oligonucleotides Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Antisense Oligonucleotides Total Market by Region (by Headquarter Location)
        1.3.1 World Antisense Oligonucleotides Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Antisense Oligonucleotides Market Size (2018-2029)
        1.3.3 China Antisense Oligonucleotides Market Size (2018-2029)
        1.3.4 Europe Antisense Oligonucleotides Market Size (2018-2029)
        1.3.5 Japan Antisense Oligonucleotides Market Size (2018-2029)
        1.3.6 South Korea Antisense Oligonucleotides Market Size (2018-2029)
        1.3.7 ASEAN Antisense Oligonucleotides Market Size (2018-2029)
        1.3.8 India Antisense Oligonucleotides Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Antisense Oligonucleotides Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Antisense Oligonucleotides Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Antisense Oligonucleotides Consumption Value (2018-2029)
    2.2 World Antisense Oligonucleotides Consumption Value by Region
        2.2.1 World Antisense Oligonucleotides Consumption Value by Region (2018-2023)
        2.2.2 World Antisense Oligonucleotides Consumption Value Forecast by Region (2024-2029)
    2.3 United States Antisense Oligonucleotides Consumption Value (2018-2029)
    2.4 China Antisense Oligonucleotides Consumption Value (2018-2029)
    2.5 Europe Antisense Oligonucleotides Consumption Value (2018-2029)
    2.6 Japan Antisense Oligonucleotides Consumption Value (2018-2029)
    2.7 South Korea Antisense Oligonucleotides Consumption Value (2018-2029)
    2.8 ASEAN Antisense Oligonucleotides Consumption Value (2018-2029)
    2.9 India Antisense Oligonucleotides Consumption Value (2018-2029)

3 World Antisense Oligonucleotides Companies Competitive Analysis
    3.1 World Antisense Oligonucleotides Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Antisense Oligonucleotides Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Antisense Oligonucleotides in 2022
        3.2.3 Global Concentration Ratios (CR8) for Antisense Oligonucleotides in 2022
    3.3 Antisense Oligonucleotides Company Evaluation Quadrant
    3.4 Antisense Oligonucleotides Market: Overall Company Footprint Analysis
        3.4.1 Antisense Oligonucleotides Market: Region Footprint
        3.4.2 Antisense Oligonucleotides Market: Company Product Type Footprint
        3.4.3 Antisense Oligonucleotides Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Antisense Oligonucleotides Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Antisense Oligonucleotides Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Antisense Oligonucleotides Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Antisense Oligonucleotides Consumption Value Comparison
        4.2.1 United States VS China: Antisense Oligonucleotides Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Antisense Oligonucleotides Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Antisense Oligonucleotides Companies and Market Share, 2018-2023
        4.3.1 United States Based Antisense Oligonucleotides Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Antisense Oligonucleotides Revenue, (2018-2023)
    4.4 China Based Companies Antisense Oligonucleotides Revenue and Market Share, 2018-2023
        4.4.1 China Based Antisense Oligonucleotides Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Antisense Oligonucleotides Revenue, (2018-2023)
    4.5 Rest of World Based Antisense Oligonucleotides Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Antisense Oligonucleotides Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Antisense Oligonucleotides Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Antisense Oligonucleotides Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 RNA Antisense Oligonucleotides
        5.2.2 DNA Antisense Oligonucleotides
    5.3 Market Segment by Type
        5.3.1 World Antisense Oligonucleotides Market Size by Type (2018-2023)
        5.3.2 World Antisense Oligonucleotides Market Size by Type (2024-2029)
        5.3.3 World Antisense Oligonucleotides Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Antisense Oligonucleotides Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Hospitals
        6.2.2 Clinic
        6.2.3 Others
    6.3 Market Segment by Application
        6.3.1 World Antisense Oligonucleotides Market Size by Application (2018-2023)
        6.3.2 World Antisense Oligonucleotides Market Size by Application (2024-2029)
        6.3.3 World Antisense Oligonucleotides Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Ionis Pharmaceuticals
        7.1.1 Ionis Pharmaceuticals Details
        7.1.2 Ionis Pharmaceuticals Major Business
        7.1.3 Ionis Pharmaceuticals Antisense Oligonucleotides Product and Services
        7.1.4 Ionis Pharmaceuticals Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Ionis Pharmaceuticals Recent Developments/Updates
        7.1.6 Ionis Pharmaceuticals Competitive Strengths & Weaknesses
    7.2 Sarepta Therapeutics
        7.2.1 Sarepta Therapeutics Details
        7.2.2 Sarepta Therapeutics Major Business
        7.2.3 Sarepta Therapeutics Antisense Oligonucleotides Product and Services
        7.2.4 Sarepta Therapeutics Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Sarepta Therapeutics Recent Developments/Updates
        7.2.6 Sarepta Therapeutics Competitive Strengths & Weaknesses
    7.3 Biogen
        7.3.1 Biogen Details
        7.3.2 Biogen Major Business
        7.3.3 Biogen Antisense Oligonucleotides Product and Services
        7.3.4 Biogen Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Biogen Recent Developments/Updates
        7.3.6 Biogen Competitive Strengths & Weaknesses
    7.4 Alnylam Pharmaceuticals
        7.4.1 Alnylam Pharmaceuticals Details
        7.4.2 Alnylam Pharmaceuticals Major Business
        7.4.3 Alnylam Pharmaceuticals Antisense Oligonucleotides Product and Services
        7.4.4 Alnylam Pharmaceuticals Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Alnylam Pharmaceuticals Recent Developments/Updates
        7.4.6 Alnylam Pharmaceuticals Competitive Strengths & Weaknesses
    7.5 Antisense Therapeutics
        7.5.1 Antisense Therapeutics Details
        7.5.2 Antisense Therapeutics Major Business
        7.5.3 Antisense Therapeutics Antisense Oligonucleotides Product and Services
        7.5.4 Antisense Therapeutics Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Antisense Therapeutics Recent Developments/Updates
        7.5.6 Antisense Therapeutics Competitive Strengths & Weaknesses
    7.6 Isarna Therapeutics
        7.6.1 Isarna Therapeutics Details
        7.6.2 Isarna Therapeutics Major Business
        7.6.3 Isarna Therapeutics Antisense Oligonucleotides Product and Services
        7.6.4 Isarna Therapeutics Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Isarna Therapeutics Recent Developments/Updates
        7.6.6 Isarna Therapeutics Competitive Strengths & Weaknesses
    7.7 Arrowhead Pharmaceuticals
        7.7.1 Arrowhead Pharmaceuticals Details
        7.7.2 Arrowhead Pharmaceuticals Major Business
        7.7.3 Arrowhead Pharmaceuticals Antisense Oligonucleotides Product and Services
        7.7.4 Arrowhead Pharmaceuticals Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Arrowhead Pharmaceuticals Recent Developments/Updates
        7.7.6 Arrowhead Pharmaceuticals Competitive Strengths & Weaknesses
    7.8 Atlantic Pharmaceuticals
        7.8.1 Atlantic Pharmaceuticals Details
        7.8.2 Atlantic Pharmaceuticals Major Business
        7.8.3 Atlantic Pharmaceuticals Antisense Oligonucleotides Product and Services
        7.8.4 Atlantic Pharmaceuticals Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Atlantic Pharmaceuticals Recent Developments/Updates
        7.8.6 Atlantic Pharmaceuticals Competitive Strengths & Weaknesses
    7.9 Enzon Pharmaceuticals
        7.9.1 Enzon Pharmaceuticals Details
        7.9.2 Enzon Pharmaceuticals Major Business
        7.9.3 Enzon Pharmaceuticals Antisense Oligonucleotides Product and Services
        7.9.4 Enzon Pharmaceuticals Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 Enzon Pharmaceuticals Recent Developments/Updates
        7.9.6 Enzon Pharmaceuticals Competitive Strengths & Weaknesses
    7.10 Bio-Path Holdings
        7.10.1 Bio-Path Holdings Details
        7.10.2 Bio-Path Holdings Major Business
        7.10.3 Bio-Path Holdings Antisense Oligonucleotides Product and Services
        7.10.4 Bio-Path Holdings Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 Bio-Path Holdings Recent Developments/Updates
        7.10.6 Bio-Path Holdings Competitive Strengths & Weaknesses
    7.11 GlaxoSmithKline
        7.11.1 GlaxoSmithKline Details
        7.11.2 GlaxoSmithKline Major Business
        7.11.3 GlaxoSmithKline Antisense Oligonucleotides Product and Services
        7.11.4 GlaxoSmithKline Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 GlaxoSmithKline Recent Developments/Updates
        7.11.6 GlaxoSmithKline Competitive Strengths & Weaknesses
    7.12 Geron
        7.12.1 Geron Details
        7.12.2 Geron Major Business
        7.12.3 Geron Antisense Oligonucleotides Product and Services
        7.12.4 Geron Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
        7.12.5 Geron Recent Developments/Updates
        7.12.6 Geron Competitive Strengths & Weaknesses
    7.13 ICO Therapeutics
        7.13.1 ICO Therapeutics Details
        7.13.2 ICO Therapeutics Major Business
        7.13.3 ICO Therapeutics Antisense Oligonucleotides Product and Services
        7.13.4 ICO Therapeutics Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
        7.13.5 ICO Therapeutics Recent Developments/Updates
        7.13.6 ICO Therapeutics Competitive Strengths & Weaknesses
    7.14 Marina Biotech
        7.14.1 Marina Biotech Details
        7.14.2 Marina Biotech Major Business
        7.14.3 Marina Biotech Antisense Oligonucleotides Product and Services
        7.14.4 Marina Biotech Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
        7.14.5 Marina Biotech Recent Developments/Updates
        7.14.6 Marina Biotech Competitive Strengths & Weaknesses
    7.15 RXi Pharmaceuticals
        7.15.1 RXi Pharmaceuticals Details
        7.15.2 RXi Pharmaceuticals Major Business
        7.15.3 RXi Pharmaceuticals Antisense Oligonucleotides Product and Services
        7.15.4 RXi Pharmaceuticals Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023)
        7.15.5 RXi Pharmaceuticals Recent Developments/Updates
        7.15.6 RXi Pharmaceuticals Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Antisense Oligonucleotides Industry Chain
    8.2 Antisense Oligonucleotides Upstream Analysis
    8.3 Antisense Oligonucleotides Midstream Analysis
    8.4 Antisense Oligonucleotides Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Antisense Oligonucleotides Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Antisense Oligonucleotides Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Antisense Oligonucleotides Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Antisense Oligonucleotides Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Antisense Oligonucleotides Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Antisense Oligonucleotides Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Antisense Oligonucleotides Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Antisense Oligonucleotides Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Antisense Oligonucleotides Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Antisense Oligonucleotides Players in 2022
    Table 12. World Antisense Oligonucleotides Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Antisense Oligonucleotides Company Evaluation Quadrant
    Table 14. Head Office of Key Antisense Oligonucleotides Player
    Table 15. Antisense Oligonucleotides Market: Company Product Type Footprint
    Table 16. Antisense Oligonucleotides Market: Company Product Application Footprint
    Table 17. Antisense Oligonucleotides Mergers & Acquisitions Activity
    Table 18. United States VS China Antisense Oligonucleotides Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Antisense Oligonucleotides Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Antisense Oligonucleotides Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Antisense Oligonucleotides Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Antisense Oligonucleotides Revenue Market Share (2018-2023)
    Table 23. China Based Antisense Oligonucleotides Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Antisense Oligonucleotides Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Antisense Oligonucleotides Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Antisense Oligonucleotides Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Antisense Oligonucleotides Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Antisense Oligonucleotides Revenue Market Share (2018-2023)
    Table 29. World Antisense Oligonucleotides Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Antisense Oligonucleotides Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Antisense Oligonucleotides Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Antisense Oligonucleotides Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Antisense Oligonucleotides Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Antisense Oligonucleotides Market Size by Application (2024-2029) & (USD Million)
    Table 35. Ionis Pharmaceuticals Basic Information, Area Served and Competitors
    Table 36. Ionis Pharmaceuticals Major Business
    Table 37. Ionis Pharmaceuticals Antisense Oligonucleotides Product and Services
    Table 38. Ionis Pharmaceuticals Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Ionis Pharmaceuticals Recent Developments/Updates
    Table 40. Ionis Pharmaceuticals Competitive Strengths & Weaknesses
    Table 41. Sarepta Therapeutics Basic Information, Area Served and Competitors
    Table 42. Sarepta Therapeutics Major Business
    Table 43. Sarepta Therapeutics Antisense Oligonucleotides Product and Services
    Table 44. Sarepta Therapeutics Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Sarepta Therapeutics Recent Developments/Updates
    Table 46. Sarepta Therapeutics Competitive Strengths & Weaknesses
    Table 47. Biogen Basic Information, Area Served and Competitors
    Table 48. Biogen Major Business
    Table 49. Biogen Antisense Oligonucleotides Product and Services
    Table 50. Biogen Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Biogen Recent Developments/Updates
    Table 52. Biogen Competitive Strengths & Weaknesses
    Table 53. Alnylam Pharmaceuticals Basic Information, Area Served and Competitors
    Table 54. Alnylam Pharmaceuticals Major Business
    Table 55. Alnylam Pharmaceuticals Antisense Oligonucleotides Product and Services
    Table 56. Alnylam Pharmaceuticals Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Alnylam Pharmaceuticals Recent Developments/Updates
    Table 58. Alnylam Pharmaceuticals Competitive Strengths & Weaknesses
    Table 59. Antisense Therapeutics Basic Information, Area Served and Competitors
    Table 60. Antisense Therapeutics Major Business
    Table 61. Antisense Therapeutics Antisense Oligonucleotides Product and Services
    Table 62. Antisense Therapeutics Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Antisense Therapeutics Recent Developments/Updates
    Table 64. Antisense Therapeutics Competitive Strengths & Weaknesses
    Table 65. Isarna Therapeutics Basic Information, Area Served and Competitors
    Table 66. Isarna Therapeutics Major Business
    Table 67. Isarna Therapeutics Antisense Oligonucleotides Product and Services
    Table 68. Isarna Therapeutics Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Isarna Therapeutics Recent Developments/Updates
    Table 70. Isarna Therapeutics Competitive Strengths & Weaknesses
    Table 71. Arrowhead Pharmaceuticals Basic Information, Area Served and Competitors
    Table 72. Arrowhead Pharmaceuticals Major Business
    Table 73. Arrowhead Pharmaceuticals Antisense Oligonucleotides Product and Services
    Table 74. Arrowhead Pharmaceuticals Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Arrowhead Pharmaceuticals Recent Developments/Updates
    Table 76. Arrowhead Pharmaceuticals Competitive Strengths & Weaknesses
    Table 77. Atlantic Pharmaceuticals Basic Information, Area Served and Competitors
    Table 78. Atlantic Pharmaceuticals Major Business
    Table 79. Atlantic Pharmaceuticals Antisense Oligonucleotides Product and Services
    Table 80. Atlantic Pharmaceuticals Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Atlantic Pharmaceuticals Recent Developments/Updates
    Table 82. Atlantic Pharmaceuticals Competitive Strengths & Weaknesses
    Table 83. Enzon Pharmaceuticals Basic Information, Area Served and Competitors
    Table 84. Enzon Pharmaceuticals Major Business
    Table 85. Enzon Pharmaceuticals Antisense Oligonucleotides Product and Services
    Table 86. Enzon Pharmaceuticals Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. Enzon Pharmaceuticals Recent Developments/Updates
    Table 88. Enzon Pharmaceuticals Competitive Strengths & Weaknesses
    Table 89. Bio-Path Holdings Basic Information, Area Served and Competitors
    Table 90. Bio-Path Holdings Major Business
    Table 91. Bio-Path Holdings Antisense Oligonucleotides Product and Services
    Table 92. Bio-Path Holdings Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. Bio-Path Holdings Recent Developments/Updates
    Table 94. Bio-Path Holdings Competitive Strengths & Weaknesses
    Table 95. GlaxoSmithKline Basic Information, Area Served and Competitors
    Table 96. GlaxoSmithKline Major Business
    Table 97. GlaxoSmithKline Antisense Oligonucleotides Product and Services
    Table 98. GlaxoSmithKline Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 99. GlaxoSmithKline Recent Developments/Updates
    Table 100. GlaxoSmithKline Competitive Strengths & Weaknesses
    Table 101. Geron Basic Information, Area Served and Competitors
    Table 102. Geron Major Business
    Table 103. Geron Antisense Oligonucleotides Product and Services
    Table 104. Geron Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 105. Geron Recent Developments/Updates
    Table 106. Geron Competitive Strengths & Weaknesses
    Table 107. ICO Therapeutics Basic Information, Area Served and Competitors
    Table 108. ICO Therapeutics Major Business
    Table 109. ICO Therapeutics Antisense Oligonucleotides Product and Services
    Table 110. ICO Therapeutics Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 111. ICO Therapeutics Recent Developments/Updates
    Table 112. ICO Therapeutics Competitive Strengths & Weaknesses
    Table 113. Marina Biotech Basic Information, Area Served and Competitors
    Table 114. Marina Biotech Major Business
    Table 115. Marina Biotech Antisense Oligonucleotides Product and Services
    Table 116. Marina Biotech Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 117. Marina Biotech Recent Developments/Updates
    Table 118. RXi Pharmaceuticals Basic Information, Area Served and Competitors
    Table 119. RXi Pharmaceuticals Major Business
    Table 120. RXi Pharmaceuticals Antisense Oligonucleotides Product and Services
    Table 121. RXi Pharmaceuticals Antisense Oligonucleotides Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 122. Global Key Players of Antisense Oligonucleotides Upstream (Raw Materials)
    Table 123. Antisense Oligonucleotides Typical Customers
List of Figure
    Figure 1. Antisense Oligonucleotides Picture
    Figure 2. World Antisense Oligonucleotides Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Antisense Oligonucleotides Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Antisense Oligonucleotides Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Antisense Oligonucleotides Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Antisense Oligonucleotides Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Antisense Oligonucleotides Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Antisense Oligonucleotides Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Antisense Oligonucleotides Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Antisense Oligonucleotides Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Antisense Oligonucleotides Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Antisense Oligonucleotides Revenue (2018-2029) & (USD Million)
    Figure 13. Antisense Oligonucleotides Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Antisense Oligonucleotides Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Antisense Oligonucleotides Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Antisense Oligonucleotides Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Antisense Oligonucleotides Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Antisense Oligonucleotides Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Antisense Oligonucleotides Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Antisense Oligonucleotides Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Antisense Oligonucleotides Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Antisense Oligonucleotides Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Antisense Oligonucleotides by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Antisense Oligonucleotides Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Antisense Oligonucleotides Markets in 2022
    Figure 27. United States VS China: Antisense Oligonucleotides Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Antisense Oligonucleotides Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Antisense Oligonucleotides Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Antisense Oligonucleotides Market Size Market Share by Type in 2022
    Figure 31. RNA Antisense Oligonucleotides
    Figure 32. DNA Antisense Oligonucleotides
    Figure 33. World Antisense Oligonucleotides Market Size Market Share by Type (2018-2029)
    Figure 34. World Antisense Oligonucleotides Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 35. World Antisense Oligonucleotides Market Size Market Share by Application in 2022
    Figure 36. Hospitals
    Figure 37. Clinic
    Figure 38. Others
    Figure 39. Antisense Oligonucleotides Industrial Chain
    Figure 40. Methodology
    Figure 41. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Antisense Oligonucleotides Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Antisense Oligonucleotides Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global Antisense Oligonucleotides market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

Antisense Oligonucleotides (ASO) Drug

Antisense oligonucleotides (ASO) Drug and siRNA Drug

Antisense Oligonucleotides

CNS Specific Antisense Oligonucleotides

Antisense Oligonucleotides-based Therapeutics

Antisense Oligonucleotides (ASO) Therapy

Antisense Oligonucleotides (ASOs) Drugs

Antisense Oligonucleotides Drugs for ATTR

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>